Control

Liver Healthcare

Fangzhou Launches Partnership for “AI + Hepatitis Prevention & Control Training Center” at the Greater Bay Area International Liver Disease Forum

admin April 18, 2025 0

GUANGZHOU, China, April 16, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven healthcare solutions,...

Does Birth Control Cause Blood Clots?

admin August 12, 2024 0

If you’re looking to avoid pregnancy, there are multiple birth control options available. These include nonhormonal kinds, such as condoms,...

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

admin May 18, 2025 0

AI in Liver Care Needs Vigilance and Tailoring to Population

admin May 16, 2025 0

Kidney Dialysis Equipment Market, In-Depth Analysis

admin May 16, 2025 0

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

admin May 16, 2025 0

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

admin May 14, 2025 0

Fangzhou Launches Partnership for “AI + Hepatitis Prevention & Control Training Center” at the Greater Bay Area International Liver Disease Forum

Does Birth Control Cause Blood Clots?

You may have missed

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

AI in Liver Care Needs Vigilance and Tailoring to Population

Kidney Dialysis Equipment Market, In-Depth Analysis

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)